Second time in a month, Indian firm recalls eye medicine from US, Health News, ET HealthWorld
CHENNAI: In a second recall within a month, Global Pharmaceuticals Healthcare has recalled artificial eye ointment lubricant due to possible contamination in the US market. The ointment is used as an eye lubricant and to relieve dryness of eyes. Early February, the Chennai-headquartered pharmaceutical company had announced a recall of artificial tears lubricant eyedrops.
Global Pharma Healthcarehowever, said when the artificial tears lubricant eyedrops were subjected to investigations, results proved there was no evidence of contamination to date.
While the announcement said the use of contaminated eye ointment may cause adverse events, including infection in the eye that could lead to blindness, the company has not received any reports of adverse events related to this product.
Furthermore, the company has notified the brand owner and importer of this product, Delsam Pharma, regarding the recall and urged wholesalers, retailers and customers, who have the recalled product, to stop any use and discard the product safely and appropriately.
When contacted, Global Pharma Healthcare told TOI, “Early in February 2023, a voluntary product recall of Ezricare/Delsam eyedrops (which were contract manufactured) was issued based on claims by the USDFDA/CDC regarding possible contamination of products. solely on testing opened bottles from various healthcare settings; in numerous cases, patients had, in fact, been using multiple brands of eyedrops. Despite there being nil complaints against Delsam eye ointment, Global Pharma Healthcare initiated a voluntary product recall out of abundance caution. “
